UNSPSC 51131642: Iloprost

This classification denotes a prostaglandin analogue and chemopreventive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JED5K35YGL. European Medicines Agency schedules Iloprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08136MIG. Iloprost generally arises in the molecular formula C22H32O4.

UNSPSC 51131642 Iloprost, a Commodity code, shows minimal relevant recent state and local procurement activity. The single identifiable opportunity in the source—Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline—is tagged as a Law Enforcement Equipment procurement, a scope unrelated to iloprost, a vasodilator pharmaceutical used in pulmonary hypertension and critical limb ischemia treatment. The mismatch between the code's pharmaceutical scope and the law enforcement equipment being solicited suggests either a coding error in the opportunity record or that iloprost is not a current focus of state and local government procurement as tracked in the available source material.

No additional recent opportunities under UNSPSC 51131642 appear in the records reviewed. State and local health departments, institutional procurement offices serving hospitals and clinics, and pharmacy cooperative purchasing vehicles would be the expected issuing bodies for iloprost procurement, but the source provides no examples of active solicitations for pharmaceutical supplies under this code. Without visible recent activity, market intelligence on geographic concentration, repeat buyers, or competitive intensity cannot be drawn from the available data.